Glucotrack, Inc. Files 8-K
Ticker: GCTK · Form: 8-K · Filed: Jan 21, 2025 · CIK: 1506983
Sentiment: neutral
Topics: sec-filing, 8-k, reporting
TL;DR
Glucotrack filed a routine 8-K, no major news.
AI Summary
Glucotrack, Inc. filed an 8-K on January 21, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This 8-K filing indicates Glucotrack, Inc. is meeting its reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not disclose any new material events or financial information that would indicate increased risk.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- January 21, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-41141 (filing_id) — SEC File Number
- 98-0668934 (tax_id) — IRS Employer Identification No.
- 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070 (address) — Address of principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to include Financial Statements and Exhibits as required by the SEC.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is January 21, 2025.
In which state is Glucotrack, Inc. incorporated?
Glucotrack, Inc. is incorporated in Delaware.
What is the SEC file number for Glucotrack, Inc.?
The SEC file number for Glucotrack, Inc. is 001-41141.
What is the principal executive office address for Glucotrack, Inc.?
The principal executive office address for Glucotrack, Inc. is 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.
Filing Stats: 504 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-21 09:15:12
Filing Documents
- form8-k.htm (8-K) — 39KB
- ex99-1.htm (EX-99.1) — 15KB
- ex99-1_001.jpg (GRAPHIC) — 10KB
- 0001493152-25-002950.txt ( ) — 243KB
- gctk-20250121.xsd (EX-101.SCH) — 3KB
- gctk-20250121_lab.xml (EX-101.LAB) — 33KB
- gctk-20250121_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 21, 2025 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer